Epoetin alfa every four weeks vs with every two weeks
Adverse events: arteriovenous complications · anaemia in predialysis patients
Epoetin alfa every four weeks showed no clear difference in adverse events: arteriovenous complications compared with with every two weeks (low certainty).
1 finding from 1 review
- Short‐acting erythropoiesis‐stimulating agents for anaemia in predialysis patients 2017 · Cochrane Headline outcomes onlyRR 1.02 [0.39, 2.68]3 studies · 724 participantsLow